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Original Article

A Dose Falloff Gradient Study in RapidArc Planning of Lung
Stereotactic Body Radiation Therapy
Ganesh Narayanasamy, Dharmin Desai1, Sanjay Maraboyina, Jose Penagaricano, Robert Zwicker2, Ellis Lee Johnson2
Depar tment of Radiation Oncology, University of Arkansas for Medical Sciences, Little Rock, AR, 1Memorial Hospital, Chattanooga, TN,
2
Depar tment of Radiation Medicine, University of Kentucky, Lexington, KY, USA

Abstract
Introduction: Radiation Therapy Oncology Group (RTOG) report #0813 and 0915 recommends using D2cm and R50% as plan quality metrics
for evaluation of normal tissue sparing in stereotactic body radiation therapy (SBRT) of lung lesion. This study introduces dose falloff
gradient (DFG) as a tool for analyzing the dose beyond the planning target volume (PTV) extending into normal tissue structures. In ascertaining
the impact of PTV size and SBRT planning techniques in DFG, this study questions the independence of the RTOG recommended metrics.
Materials and Methods: In this retrospective study, 41 RapidArc lung SBRT plans with 2 or 3 complete or partial arcs were analyzed. PTV
volumes ranged between 5.3 and 113 cm3 and their geographic locations were distributed in both lungs. 6MV, 6 MV‑FFF, 10 MV, or 10 MV‑FFF
energies were used. RTOG‑0915 metrics conformity index, homogeneity index, D2cm, R50%, and HDloc were evaluated. DFG was computed
from the mean and maximum dose in seven concentric 5 mm wide rings outside the PTV. DFG was investigated against the volume of normal
lung irradiated by 50% isodose volume. Treatment plans with alternate energy and couch rotations were generated. Results: The dose falloff
beyond PTV was modeled using a double exponential fit and evaluated for relationship with intermediate lung dose. Photon energy and beam
configuration had a minimal impact on the dose falloff outside. The product of normalized D2cm and R50% was estimated to have a slowly
varying value. Conclusions: Dose falloff outside PTV has been studied as a function of radial distance and ascertained by intermediate dose
to normal lung. DFG can serve as a complementary plan quality metric.
Keywords: Dose falloff, dose gradient, lung stereotactic body radiation therapy, stereotactic body radiation therapy dose falloff,
stereotactic body radiation therapy planning
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Review completed on: 11-07-2018

Introduction
Stereotactic body radiation therapy (SBRT) is a leading
treatment modality, especially for early‑stage nonsmall cell
lung cancer. SBRT involves small size radiation fields with
sharp dose falloff and image‑guided localization.[1] Potential
advantages of SBRT include a higher biological effective dose
and greater delivery efficiency with volumetric‑modulated arc
therapy (VMAT).[2,3] Similar to intensity‑modulated radiation
therapy (IMRT), RapidArc planning technique in Eclipse
treatment planning system (Varian Medical Systems, Palo
Alto, CA, USA) based on VMAT has the ability to produce
conformal dose distribution around the target, reducing dose
to organs at risk (OAR).[4‑8]
In plan evaluation, metrics such as volume of normal lung
irradiated by 20 Gy (V20) present an incomplete view of the
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dose falloff to the normal tissue. R50% and D2cm were used to
assess the intermediate‑to‑low dose spillage outside the PTV.
HDloc was recommended to evaluate the high‑dose (>105%)
spill outside the PTV. However, both R50% and D2cm could
include regions outside the lung tissue or ribs that may not
have known dose tolerance or clinical end‑points. Conversely,
D2cm is estimated isotropically at 2 cm distance from PTV
surface without taking water equivalent path length into
account. In this study, we have identified a trend in the R50%
and D2cm data questioning their independence that is worth
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exploring. In addition, neither of these metrics could correlate
with the excessive toxicity observed when treating central
lung tumors using SBRT.[9] In this study, we propose to study
the normal tissue toxicity using exponential dose falloff
gradient (DFG)[10] that can be directly related to the normal
lung volume irradiated. To study the impact of planning
techniques on the dose falloff, plans with alternate coplanar/
noncoplanar arc configuration and alternate photon energy
were also utilized.

or noncoplanar field configuration with up to ± 15° couch
rotation was generated.

Materials and Methods

Plans were normalized such that 95% of PTV received the
prescription dose (Rx) of 48–55 Gy. Among the 41 clinical
plans, 35 plans involved couch rotations ranging between 0°
and 30° with a mean ± standard deviation (SD) of 16.1° ± 9.8°.
Dose constraints to the OARs include maximum point dose of
18 Gy to spinal cord, 30 Gy to heart, 24 Gy to brachial plexus,
30 Gy to trachea, and a mean dose of 27 Gy to esophagus as
well as maximum percent V20 of 15%. Dose calculation grid
size was set at 2 mm for SBRT at our institution.

Patient data

Thorax phantom study

This study was approved by the institutional review
board. Forty‑one lung tumor patients previously treated
with VMAT‑based SBRT were included in this study.
Four‑dimensional computed tomography (4D‑CT) scanning
was performed in GE‑Discovery CT scanner (GE Medical
Systems, Waukesha, WI, USA) and CT images were
reconstructed at 2 mm slice spacing. The 4D‑CT image data
were sorted into 10 phase bins ranging from 0% to 90% with
0% phase being end‑inspiration and 90% phase end‑expiration.
The maximum intensity projection images were used in
generating an internal target volume (ITV). ITV is grown into
PTV anisotropically using 10, 5, and 5 mm margins along
longitudinal, lateral, and anterior‑posterior axes, respectively.
Table 1 shows the patient statistics.
V M AT‑ b a s e d S B RT p l a n w a s c a l c u l a t e d o n t h e
respiration‑averaged CT of the ten phases of 4D‑CT using
Acuros XB dose calculation algorithm on Eclipse treatment
planning software version 11.0 (Varian Medical System, Palo
Alto, CA, USA). RapidArc technique was used for delivery
on either a Novalis Tx or a TrueBeam™ STx equipped with
high‑definition multileaf collimators. SBRT plans were
created using either 2 or 3 complete or partial arcs based on
6MV, 6 MV‑FFF, 10 MV, or 10 MV‑FFF energies. Coplanar
Table 1: The maximum, minimum, average and
standard deviation of Rx dose (Gy), number of MUs,
normalization (%), planning target volume (cm3),
equivalent diameter (cm), number of arcs, total gantry
span, and total couch span of the 41 lung tumor
stereotactic body radiation therapy patient plans
Maximum

Minimum

Average

Rx dose (Gy)
55
48
49.3
Total MU
27712
10194
16065.0
Normalization (%)
94
62
76.5
Volume of PTV (cm3)
112.7
5.3
30.9
PTV equivalent
6
2.2
3.63
diameter (cm)
# arcs
3
2
2.2
Total gantry rotation
716
388
509.1
span (°)
Total couch rotation
30
0
16.1
span (°)
PTV: Planning target volume, SD: Standard deviation
148

SD
1.75
3383.4
14.1
26.4
1.0
0.4
119.0
9.8

A phantom study was contrived to (a) study the asymmetrical
spread in spatial dose distribution around the lung tumor
number and (b) identify the optimum width of rings outside the
PTV for dose falloff calculations. While the former is intended
to address the predominantly coplanar dose distribution due
to large fraction of coplanar beams in our clinical plans,
the latter facilitates dose evaluation outside PTV in a lung
SBRT plan. The steep dose falloff along the longitudinal
axis was known to skew the spatial dose distribution and a
“ring terminator” region can be considered similar to setting
a low‑dose threshold. The longitudinal and lateral extents of
the “ring terminator” region are identified using linear dose
profile measurement. While thin rings may explore dose falloff
accurately, they could be impaired by noise fluctuations. On the
other hand, wider rings may suffer from low spatial resolution.
The slope of mean and maximum dose falloffs and the rate of
change of slope that corresponds to curvature were computed.
These measurements were compared for the four ring sizes
considered here, 2.5 mm, 5 mm, 7.5 mm, and 10 mm width.
A thorax phantom (Model 002 LFC; CIRS Inc., Norfolk, VA,
USA) with spherical lung lesions varying between 5, 10, 20,
40, and 80 cm3 was used in this study. A VMAT SBRT plan was
created for each target meeting the clinical dose coverage. The
target coverage, dose conformity, and mean and maximum dose in
the rings were evaluated in addition to the proposed metric, DFG.

Radiation Therapy Oncology Group plan quality metrics

Radiation Therapy Oncology Group (RTOG) report #0915
treatment plan quality metrics include the conformity
index (CI) of the target coverage which is defined as the ratio
of prescription isodose volume to the volume of PTV.
CI = �

PIV
(1)
PTV

Dose homogeneity index (HI) within the target can be
estimated using the ratio of differences between the doses
delivered to 2% and 98% of volume with the median dose to
the PTV, which was originally proposed in ICRU‑83.[11]
HI =

( D2% − D98% )

(2)
D50%
For estimation of dose falloff outside the target, RTOG
recommended metrics evaluated include R50%, D2cm, and HDloc.
Journal of Medical Physics ¦ Volume 43 ¦ Issue 3 ¦ July-September 2018
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50% Rx isodose volume
(3)
PTV Volume

“imitate” Gamma Knife treatments using linear accelerator for
extracranial sites, there was limited clinical feasibility.

D2cm is defined as the maximum dose (in % of prescribed
dose) at a point 2 cm away from the surface of PTV along
any direction. For estimation of high‑dose spillage (HDloc),
volume of 105% isodose volume outside the PTV is estimated
as a ratio of the volume of PTV.

The use of FFF beams with cone‑shaped profile could alter
the dose statistics including RTOG metrics, dose to OARs
in a lung SBRT plan besides reduced treatment time. In the
second alternate planning strategy, photon energy of 6MV was
replaced by 6 MV‑FFF and vice versa. Likewise, 10 MV photon
beam was replaced by 10 MV‑FFF and vice versa.

R50% =

HDloc =

105% Rx isodose volume outside PTV
(4)
PTV Volume

Published tables provide desirable range of values for these
metrics.[12] Dose falloff product (DFP) defined as the product
of D2cm and R50% was introduced to study the dependence of the
two metrics (D2cm and R50%) on one another by investigating
the relationship between DFP and PTV. An SBRT plan of
high quality would have low values for R50%, D2cm, HDloc as
well as DFP.

Dose falloff

In evaluating IMRT and VMAT plans, the peripheral dose to
the OARs may need the spatial dose distribution in addition to
dose–volume histogram (DVH) statistics. The proposed dose
falloff was modeled as a double exponential fit of the radial
distance (r) from the PTV surface in the form:
%DD ( r ) = A1e − a1r + A2e − a 2 r (5)
where A1, a1, A2, and a2 refer to fitting coefficients and
%DD (r) denotes the dose as a percent of the Rx at a radial
distance r (mm) from PTV. Value of the coefficients was
obtained using the statistics toolbox in Matlab ver R2016a
(The Mathworks, Inc., Natick, MA, USA). The first and
second terms in Equation 5 represents steep and shallow
exponential dose falloff. Notice that as r approaches 0,
the first term dominates and as r approaches large clinical
distances, the second term dominates. By definition, steep
DFG is numerically equal to a1 and the shallow DFG is
a2. A large DFG implies fast dose falloff outside PTV and
less volume of normal lung tissue irradiation which holds
significance in our study. The relationship between DFG
and the 50% isodose volume irradiating the normal lung
(outside PTV and not including the chest wall or ribs) is
studied on the patient plans.

Alternate planning strategy

The aim of the alternate planning strategies was to study any
reduction in dose to normal tissue in addition to improved
RTOG metrics. Alternate research plans utilize two strategies.
In the first method, all noncoplanar beams were changed to
coplanar beams, and dose was computed after plan optimization
for coplanar beam arrangement. This would test the hypothesis
that the altered footprint of radiation passing through the
patient’s body would change the low and intermediate dose
levels. Papiez et al. had postulated steep dose falloff from
multiple noncoplanar, nondivergent beams in extracranial
stereotactic radioablation.[13] While the authors attempted to
Journal of Medical Physics ¦ Volume 43 ¦ Issue 3 ¦ July-September 2018

DVH‑based statistics from the two alternate plans were
compared against DVH of the clinical plan. Plans were
evaluated according to the following parameters: CI, R50%,
D2cm, HDloc, DFG, and dose to OARs.

Statistical analysis

The dose statistics from the alternate plans were compared to
the clinical plan. Test for normal distribution was performed
using Shapiro-Wilk test in R statistical software ver 3.2.0
(R Development Core Team).[14] Statistical significance was tested
using a paired Student’s t‑test for normally distributed data and a
Wilcoxon signed‑rank test, otherwise with a threshold P = 0.05.

Results
Radiation therapy oncology group patient plan quality
metrics

Clinical plan metrics met the RTOG reports 0813,[15] 0915[16]
guidelines tabulated in Table 2. The CI values have an average
of 1.1 (range: 0.99–1.24) which is close to the value of 1.2
for acceptable plan. Based on PTV, the plans should have
R50% values <3.2–5.3 for an acceptable plan and <4.2–6.3
for a plan with minor deviation. The observed values of D2cm
ranged within 43.0%–74.1% and are well within the range of
an acceptable plan or a plan with minor deviation. An ideal plan
should have values of HDloc <0.15 which was observed in all
the patient plans. The mean ± SD of DFP was 253 ± 36 for the
patient plans. Figure 1 shows the relationship of DFP and PTV
with a slope of −0.016 and R2 of 10−4. Such a small value of
slope implies a negligible change in DFP with PTVs observed
in lung tumor patients treated with SBRT at our institution.
This indicates that DFP is independent of PTV which implies
that D2cm and R50% may not be independent of each other.

Dosimetry – thorax phantom plan

A thorax phantom plan with multiple rings outside the PTV
and the ring terminator region is displayed in Figure 2. Linear
dose profiles outlined in Figure 3 confirms a steeper dose falloff
along the longitudinal axis than along a lateral side of the
phantom. Figure 3 also confirms that dose drops off to <10%
of Rx dose at distances of 1 cm along the longitudinal and
4 cm along the lateral direction from the PTV surface. These
were considered as extents of the “ring terminator” region, and
dose outside this region could be neglected without an impact
on the dose statistics.
Figure 4 displays the rate of change of slope of the maximum
dose (measured in cGy/mm2) for the 4 ring widths considered.
149
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Table 2: Statistics of the quality metrics from patient plans along with the acceptable range and the number of plans
outside the scope of a minor deviation, as per Radiation Therapy Oncology Group‑0915 specifications
Minimum

Maximum

Average

SD

RTOG‑0915
acceptable range

RTOG‑0915 minor
deviation

Number of plans with
major deviation

CI
0.99
1.24
1.1
0.1
<1.2
<1.5
0
HI
0.1
0.3
0.2
0.1
NA
NA
NA
R50%
3.3
6.7
4.6
0.7
<3.2‑5.3
<4.2‑6.3
1
D2cm
43.0
74.1
55.0
6.8
<50.0‑71.7
<57.4‑90.1
0
HDloc
0.0
0.1
0.01
0.02
<0.15
NA
0
DFP
189
333.5
253
35.9
NA
NA
NA
HI: Homogeneity index, CI: Conformity index, DFP: Dose falloff product, HDloc: High‑dose spillage, NA: Not available, SD: Standard deviation,
RTOG: Radiation Therapy Oncology Group

Figure 1: Plot showing the values of dose falloff product with the volume
of PTV. The solid line represents trend line represented by the equation
while dashed lines shows twice standard deviation

The huge fluctuations in rate of change in slope observed
in 2.5 mm ring data hinder their usage. With low spatial
resolution, the 7.5 mm and 10 mm rings fail to capture the
trend or curvature of dose falloff outside the PTV. In addition,
the number of rings has to be sufficient to study the dose
falloff down to <10% of Rx dose. An optimum choice was
determined to be 7 rings of 5 mm width. Figure 5 shows the
maximum and mean dose falloff as well as DFG for 100%
target coverage.

Dose falloff – patient plans

The maximum and mean dose falloffs with distance from
PTV were plotted in Figure 6 for patient plans. Using
Equation 5 to fit the dose falloff, values of the fitting
coefficients for the maximum dose falloff in the patient
plans were:
A1 = 65.7 ± 8.1 (%); a1 = 0.094 ± 0.016 (1/mm)
A2 = 50.8 ± 9.7 (%); a2 = 0.006 ± 0.005 (1/mm)
It can be noticed that the values of steep DFG (a1) are larger
than the slow DFG (a2) by one order of magnitude and the slow
dose falloff term can be replaced by a constant for distances
of clinical interest. Notice that although DFG of maximum
doses decrease with increasing PTV, there is no such trend in
the DFG of mean doses with PTV.
150

Figure 2: Cross‑sectional views of a representative patient’s
volumetric‑modulated arc therapy‑based stereotactic body radiation
therapy plan showing seven 5 mm wide rings generated concentric with
the PTV surface. Also seen is the ring terminator with 1 cm gap from the
superior and inferior extremes of the PTV surface

DFG of the maximum dose was hypothesized to have a trend
with the intermediate‑to‑low isodose volumes. The 50% Rx
isodose volume has been observed to decrease with PTV and
expected to be lower in a plan with higher DFG. By normalizing
with the PTV, the volume of normal lung irradiated by 50%
isodose volume (VNL50%) has been evaluated against DFG.
Figure 7 displays exponentially decreasing relation of VNL50%
normalized to PTV with DFG of maximum dose. Note that
VNL50% is calculated from the intersection of bilateral lungs
with 50% isodose volume and could be extended to estimate
V20 or mean lung dose. However, R50% calculation could include
chest wall, ribs, and other organs outside the lungs.

Plan Quality Metrics – Alternate Plans
The alternate plans were reoptimized to meet the target
coverage and OAR dose constraints. Barring R50% of one
clinical plan, the values of both D2cm and R50% of all the clinical
plans can be considered acceptable or with minor deviation, as
shown in Figures 8 and 9, respectively. Among the coplanar
plans, 4 and 5 patients had major deviations in D2cm and R50%,
respectively. Corresponding numbers for alternate energy plans
were 4 and 7 patients.
Journal of Medical Physics ¦ Volume 43 ¦ Issue 3 ¦ July-September 2018
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a

b

Figure 3: Point dose falloff along the (a) right and (b) superior direction as a function of distance from the PTV surface in a patient plan shows moderate
and steep gradient, respectively

quantified by DFG derived from Equation 5. The contrasting
dose falloff along axial and longitudinal axes illustrated in
Figure 3 agrees with similar results from an extracranial
SBRT study.[13] The authors studied the isotropicity of dose
distribution and gradient of dose falloff in regions adjacent
and away from the tumor boundary. For a target with
significant longitudinal movement seen in lung tumors, this
dose distribution presents a potential risk of marginal miss,
especially when small PTV margins are used.

Figure 4: Rate of change of slope of the maximum dose (cGy/mm2) for
the 4 ring widths in thorax phantom

Statistical significance – alternate plans

None of these metrics (CI, HI, HDloc, D2cm, and R50%) of the
alternate plans displayed significant differences with the
clinical plans at 5% threshold.

Discussion
The analysis of SBRT plans of lung tumor showed that R50%
and D2cm were, respectively, decreasing and increasing with
PTV. Similar values of R50% and D2cm were reported by a
phase III multicenter randomized trial (ROSEL) on Stage 1A
lung cancer.[17] To the best of our knowledge, this is the first
study which revealed that the product of these two metrics,
DFP has slowly varying value which questions the complete
independence of R50% and D2cm. This study questions the need
to have two metrics when either one could perform this job
equally well. It is evident from Figures 8 and 9 that RTOG
constraints on D2cm can be easier to meet than those of R50%,
thereby suggesting that R50% is possibly a superior metric.
In this study, the dose falloff outside PTV in lung SBRT plans
that take the spatial dose distribution was taken into account.
Our analysis shows that asymmetric dose distribution, possibly
due to beam arrangement or avoidance structures, can be
Journal of Medical Physics ¦ Volume 43 ¦ Issue 3 ¦ July-September 2018

Equation 5 is a fitting function for the dose distribution in the
region outside PTV. For the 41 plans studied here, V50% of
normal lung normalized by the PTV was found to decrease
exponentially with DFG of maximum dose. From a known
DFG, one can estimate VNL50% or any intermediate dose
including, V20. Thus, DFG can be used as a surrogate of normal
lung irradiation with high DFG symbolizing low percent of
normal lung irradiated by intermediate dose, as shown in
Figure 7. Although not considered during plan optimization,
the radial dose dependence dropoff measured by DFG can be
used as a complementary measure.
Alternate treatment plans were created to study the effect of
beam arrangement and beam energy on dose reduction to
normal tissue. In a 37 lung cancer patient SBRT study, Lim
et al. found that multiple noncoplanar static fields produce
significantly lower R50% than multiple coplanar static fields or
VMAT.[18] In a retrospective study on 15 lung cancer patients,
VMAT plans scored substantially better RTOG metrics than
3D plans, and noncoplanar VMAT plans were slightly better
than coplanar VMAT plans.[19] In our study, 4 and 5 coplanar
plans had a major deviations in D2cm and R50%, respectively,
while the corresponding numbers were 1 and 0 in noncoplanar
plans. However, a significant gain in dose to OARs or RTOG
metrics was not observed in our study using noncoplanar arcs
(P > 0.1 in Wilcoxon signed‑rank test). Possible explanations
could be the amount of noncoplanarity from about ± 15° couch
angle limitation due to collision issues and lack of statistical
power. It is feasible to achieve better results on lateral tumors
and smaller sized patients where the couch angle could be
larger. The main advantage of noncoplanar arc and FFF beams
is the ability to spare critical organs with additional degrees
151
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a

b

c

d

Figure 5: (a) Maximum dose falloff (%) from the PTV surface and (b) maximum dose falloff gradient (1/mm) as a function of PTV volumes in the thorax
phantom. (c) Mean dose falloff (%) from the PTV surface and (d) mean dose falloff gradient (1/mm) as a function of PTV volumes in the thorax phantom

a

b

c

d

Figure 6: (a) Maximum dose falloff (%) from the PTV surface and (b) maximum dose falloff gradient (1/mm) as a function of PTV volumes in the patient
plans. (c) Mean dose falloff (%) from the PTV surface and (d) mean dose falloff gradient (1/mm) as a function of PTV volumes in the patient plans

of freedom.[20,21] Zhang et al. had demonstrated slightly better
RTOG metrics for noncoplanar VMAT plans with FFF beams
than their flattened counterpart beams, with the exception of
152

number of monitor units.[19] Higher MUs in FFF beams does
not necessarily imply large peripheral doses due to lower
head leakage with the absence of flattening filter. In fact,
Journal of Medical Physics ¦ Volume 43 ¦ Issue 3 ¦ July-September 2018
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were lower,[22] both of which were correlated to pneumonitis.
The dose rate of FFF beams is substantially higher than
conventional beams leading to lower treatment time and less
chances of patient motion. In a 132 lung cancer patient study,
Navarria et al. had concluded that SBRT with FFF beams
permitted safe delivery of high dose per fraction in a short
treatment time resulting in an earlier radiological response
compared with FF beams.[23]

Conclusions
Figure 7: Normalized 50% Rx isodose volume irradiating the normal lung
as a function of dose falloff gradient of maximum dose

An exponential fit function was attempted to study the
dose distribution outside the PTV from which dose falloff
coefficients, namely, DFG were extracted. This new variable
was used to evaluate dose to the normal tissue outside the
PTV and could act as an SBRT DFG in addition to other
metrics. In addition, DFG could be used to predict the percent
of normal lung receiving medium‑to‑intermediate dose. The
independence of RTOG recommended metrics, R50%, and D2cm
was found to be questionable, although further research is
required for conclusive evidence.
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